Global Nuclear Medicine Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
According to APO Research, The global Nuclear Medicine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Nuclear Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Nuclear Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Nuclear Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Nuclear Medicine include GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Triad Isotopes, Nordion, Jubilant Pharma and Eli Lilly, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine.
The Nuclear Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Nuclear Medicine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
According to APO Research, The global Nuclear Medicine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Nuclear Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Nuclear Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Nuclear Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Nuclear Medicine include GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Triad Isotopes, Nordion, Jubilant Pharma and Eli Lilly, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine.
The Nuclear Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- GE Healthcare
- Bracco Imaging
- Mallinckrodt
- Lantheus Medical Imaging
- Bayer
- Triad Isotopes
- Nordion
- Jubilant Pharma
- Eli Lilly
- SIEMENS
- China Isotope & Radiation
- Dongcheng
- Tc-99
- I-123/131
- In-111
- Xe-133
- Th-201
- Ga-67
- Others
- Diagnostic
- Therapeutic
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Nuclear Medicine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Nuclear Medicine Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Nuclear Medicine Market Size by Region (2019-2030)
1.4.1 Global Nuclear Medicine Market Size by Region (2019-2024)
1.4.2 Global Nuclear Medicine Market Size by Region (2025-2030)
1.5 Key Regions Nuclear Medicine Market Size (2019-2030)
1.5.1 North America Nuclear Medicine Market Size Growth Rate (2019-2030)
1.5.2 Europe Nuclear Medicine Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Nuclear Medicine Market Size Growth Rate (2019-2030)
1.5.4 Latin America Nuclear Medicine Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Nuclear Medicine Market Size Growth Rate (2019-2030)
2 NUCLEAR MEDICINE MARKET BY TYPE
2.1 Type Introduction
2.1.1 Tc-99
2.1.2 I-123/131
2.1.3 In-111
2.1.4 Xe-133
2.1.5 Th-201
2.1.6 Ga-67
2.1.7 Others
2.2 Global Nuclear Medicine Market Size by Type
2.2.1 Global Nuclear Medicine Market Size Overview by Type (2019-2030)
2.2.2 Global Nuclear Medicine Historic Market Size Review by Type (2019-2024)
2.2.3 Global Nuclear Medicine Market Size Forecasted by Type (2025-2030)
2.3 Global Nuclear Medicine Market Size by Regions
2.3.1 North America Nuclear Medicine Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Nuclear Medicine Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Nuclear Medicine Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Nuclear Medicine Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Nuclear Medicine Market Size Breakdown by Type (2019-2024)
3 NUCLEAR MEDICINE MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Diagnostic
3.1.2 Therapeutic
3.2 Global Nuclear Medicine Market Size by Application
3.2.1 Global Nuclear Medicine Market Size Overview by Application (2019-2030)
3.2.2 Global Nuclear Medicine Historic Market Size Review by Application (2019-2024)
3.2.3 Global Nuclear Medicine Market Size Forecasted by Application (2025-2030)
3.3 Global Nuclear Medicine Market Size by Regions
3.3.1 North America Nuclear Medicine Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Nuclear Medicine Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Nuclear Medicine Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Nuclear Medicine Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Nuclear Medicine Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Nuclear Medicine Industry Trends
4.2 Nuclear Medicine Industry Drivers
4.3 Nuclear Medicine Industry Opportunities and Challenges
4.4 Nuclear Medicine Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Nuclear Medicine Revenue (2019-2024)
5.2 Global Nuclear Medicine Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Nuclear Medicine Key Company Headquarters & Area Served
5.4 Global Nuclear Medicine Company, Product Type & Application
5.5 Global Nuclear Medicine Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Nuclear Medicine Market CR5 and HHI
5.6.2 Global Top 5 and 10 Nuclear Medicine Players Market Share by Revenue in 2023
5.6.3 2023 Nuclear Medicine Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 GE Healthcare
6.1.1 GE Healthcare Comapny Information
6.1.2 GE Healthcare Business Overview
6.1.3 GE Healthcare Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 GE Healthcare Nuclear Medicine Product Portfolio
6.1.5 GE Healthcare Recent Developments
6.2 Bracco Imaging
6.2.1 Bracco Imaging Comapny Information
6.2.2 Bracco Imaging Business Overview
6.2.3 Bracco Imaging Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Bracco Imaging Nuclear Medicine Product Portfolio
6.2.5 Bracco Imaging Recent Developments
6.3 Mallinckrodt
6.3.1 Mallinckrodt Comapny Information
6.3.2 Mallinckrodt Business Overview
6.3.3 Mallinckrodt Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Mallinckrodt Nuclear Medicine Product Portfolio
6.3.5 Mallinckrodt Recent Developments
6.4 Lantheus Medical Imaging
6.4.1 Lantheus Medical Imaging Comapny Information
6.4.2 Lantheus Medical Imaging Business Overview
6.4.3 Lantheus Medical Imaging Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Lantheus Medical Imaging Nuclear Medicine Product Portfolio
6.4.5 Lantheus Medical Imaging Recent Developments
6.5 Bayer
6.5.1 Bayer Comapny Information
6.5.2 Bayer Business Overview
6.5.3 Bayer Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Bayer Nuclear Medicine Product Portfolio
6.5.5 Bayer Recent Developments
6.6 Triad Isotopes
6.6.1 Triad Isotopes Comapny Information
6.6.2 Triad Isotopes Business Overview
6.6.3 Triad Isotopes Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Triad Isotopes Nuclear Medicine Product Portfolio
6.6.5 Triad Isotopes Recent Developments
6.7 Nordion
6.7.1 Nordion Comapny Information
6.7.2 Nordion Business Overview
6.7.3 Nordion Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Nordion Nuclear Medicine Product Portfolio
6.7.5 Nordion Recent Developments
6.8 Jubilant Pharma
6.8.1 Jubilant Pharma Comapny Information
6.8.2 Jubilant Pharma Business Overview
6.8.3 Jubilant Pharma Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Jubilant Pharma Nuclear Medicine Product Portfolio
6.8.5 Jubilant Pharma Recent Developments
6.9 Eli Lilly
6.9.1 Eli Lilly Comapny Information
6.9.2 Eli Lilly Business Overview
6.9.3 Eli Lilly Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Eli Lilly Nuclear Medicine Product Portfolio
6.9.5 Eli Lilly Recent Developments
6.10 SIEMENS
6.10.1 SIEMENS Comapny Information
6.10.2 SIEMENS Business Overview
6.10.3 SIEMENS Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 SIEMENS Nuclear Medicine Product Portfolio
6.10.5 SIEMENS Recent Developments
6.11 China Isotope & Radiation
6.11.1 China Isotope & Radiation Comapny Information
6.11.2 China Isotope & Radiation Business Overview
6.11.3 China Isotope & Radiation Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 China Isotope & Radiation Nuclear Medicine Product Portfolio
6.11.5 China Isotope & Radiation Recent Developments
6.12 Dongcheng
6.12.1 Dongcheng Comapny Information
6.12.2 Dongcheng Business Overview
6.12.3 Dongcheng Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Dongcheng Nuclear Medicine Product Portfolio
6.12.5 Dongcheng Recent Developments
7 NORTH AMERICA
7.1 North America Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Nuclear Medicine Market Size by Country (2019-2024)
7.3 North America Nuclear Medicine Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Nuclear Medicine Market Size by Country (2019-2024)
8.3 Europe Nuclear Medicine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Nuclear Medicine Market Size by Country (2019-2024)
9.3 Asia-Pacific Nuclear Medicine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Nuclear Medicine Market Size by Country (2019-2024)
10.3 Latin America Nuclear Medicine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Nuclear Medicine Market Size by Country (2019-2024)
11.3 Middle East & Africa Nuclear Medicine Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Nuclear Medicine Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Nuclear Medicine Market Size by Region (2019-2030)
1.4.1 Global Nuclear Medicine Market Size by Region (2019-2024)
1.4.2 Global Nuclear Medicine Market Size by Region (2025-2030)
1.5 Key Regions Nuclear Medicine Market Size (2019-2030)
1.5.1 North America Nuclear Medicine Market Size Growth Rate (2019-2030)
1.5.2 Europe Nuclear Medicine Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Nuclear Medicine Market Size Growth Rate (2019-2030)
1.5.4 Latin America Nuclear Medicine Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Nuclear Medicine Market Size Growth Rate (2019-2030)
2 NUCLEAR MEDICINE MARKET BY TYPE
2.1 Type Introduction
2.1.1 Tc-99
2.1.2 I-123/131
2.1.3 In-111
2.1.4 Xe-133
2.1.5 Th-201
2.1.6 Ga-67
2.1.7 Others
2.2 Global Nuclear Medicine Market Size by Type
2.2.1 Global Nuclear Medicine Market Size Overview by Type (2019-2030)
2.2.2 Global Nuclear Medicine Historic Market Size Review by Type (2019-2024)
2.2.3 Global Nuclear Medicine Market Size Forecasted by Type (2025-2030)
2.3 Global Nuclear Medicine Market Size by Regions
2.3.1 North America Nuclear Medicine Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Nuclear Medicine Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Nuclear Medicine Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Nuclear Medicine Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Nuclear Medicine Market Size Breakdown by Type (2019-2024)
3 NUCLEAR MEDICINE MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Diagnostic
3.1.2 Therapeutic
3.2 Global Nuclear Medicine Market Size by Application
3.2.1 Global Nuclear Medicine Market Size Overview by Application (2019-2030)
3.2.2 Global Nuclear Medicine Historic Market Size Review by Application (2019-2024)
3.2.3 Global Nuclear Medicine Market Size Forecasted by Application (2025-2030)
3.3 Global Nuclear Medicine Market Size by Regions
3.3.1 North America Nuclear Medicine Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Nuclear Medicine Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Nuclear Medicine Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Nuclear Medicine Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Nuclear Medicine Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Nuclear Medicine Industry Trends
4.2 Nuclear Medicine Industry Drivers
4.3 Nuclear Medicine Industry Opportunities and Challenges
4.4 Nuclear Medicine Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Nuclear Medicine Revenue (2019-2024)
5.2 Global Nuclear Medicine Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Nuclear Medicine Key Company Headquarters & Area Served
5.4 Global Nuclear Medicine Company, Product Type & Application
5.5 Global Nuclear Medicine Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Nuclear Medicine Market CR5 and HHI
5.6.2 Global Top 5 and 10 Nuclear Medicine Players Market Share by Revenue in 2023
5.6.3 2023 Nuclear Medicine Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 GE Healthcare
6.1.1 GE Healthcare Comapny Information
6.1.2 GE Healthcare Business Overview
6.1.3 GE Healthcare Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 GE Healthcare Nuclear Medicine Product Portfolio
6.1.5 GE Healthcare Recent Developments
6.2 Bracco Imaging
6.2.1 Bracco Imaging Comapny Information
6.2.2 Bracco Imaging Business Overview
6.2.3 Bracco Imaging Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Bracco Imaging Nuclear Medicine Product Portfolio
6.2.5 Bracco Imaging Recent Developments
6.3 Mallinckrodt
6.3.1 Mallinckrodt Comapny Information
6.3.2 Mallinckrodt Business Overview
6.3.3 Mallinckrodt Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Mallinckrodt Nuclear Medicine Product Portfolio
6.3.5 Mallinckrodt Recent Developments
6.4 Lantheus Medical Imaging
6.4.1 Lantheus Medical Imaging Comapny Information
6.4.2 Lantheus Medical Imaging Business Overview
6.4.3 Lantheus Medical Imaging Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Lantheus Medical Imaging Nuclear Medicine Product Portfolio
6.4.5 Lantheus Medical Imaging Recent Developments
6.5 Bayer
6.5.1 Bayer Comapny Information
6.5.2 Bayer Business Overview
6.5.3 Bayer Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Bayer Nuclear Medicine Product Portfolio
6.5.5 Bayer Recent Developments
6.6 Triad Isotopes
6.6.1 Triad Isotopes Comapny Information
6.6.2 Triad Isotopes Business Overview
6.6.3 Triad Isotopes Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Triad Isotopes Nuclear Medicine Product Portfolio
6.6.5 Triad Isotopes Recent Developments
6.7 Nordion
6.7.1 Nordion Comapny Information
6.7.2 Nordion Business Overview
6.7.3 Nordion Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Nordion Nuclear Medicine Product Portfolio
6.7.5 Nordion Recent Developments
6.8 Jubilant Pharma
6.8.1 Jubilant Pharma Comapny Information
6.8.2 Jubilant Pharma Business Overview
6.8.3 Jubilant Pharma Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Jubilant Pharma Nuclear Medicine Product Portfolio
6.8.5 Jubilant Pharma Recent Developments
6.9 Eli Lilly
6.9.1 Eli Lilly Comapny Information
6.9.2 Eli Lilly Business Overview
6.9.3 Eli Lilly Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Eli Lilly Nuclear Medicine Product Portfolio
6.9.5 Eli Lilly Recent Developments
6.10 SIEMENS
6.10.1 SIEMENS Comapny Information
6.10.2 SIEMENS Business Overview
6.10.3 SIEMENS Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 SIEMENS Nuclear Medicine Product Portfolio
6.10.5 SIEMENS Recent Developments
6.11 China Isotope & Radiation
6.11.1 China Isotope & Radiation Comapny Information
6.11.2 China Isotope & Radiation Business Overview
6.11.3 China Isotope & Radiation Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 China Isotope & Radiation Nuclear Medicine Product Portfolio
6.11.5 China Isotope & Radiation Recent Developments
6.12 Dongcheng
6.12.1 Dongcheng Comapny Information
6.12.2 Dongcheng Business Overview
6.12.3 Dongcheng Nuclear Medicine Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Dongcheng Nuclear Medicine Product Portfolio
6.12.5 Dongcheng Recent Developments
7 NORTH AMERICA
7.1 North America Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Nuclear Medicine Market Size by Country (2019-2024)
7.3 North America Nuclear Medicine Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Nuclear Medicine Market Size by Country (2019-2024)
8.3 Europe Nuclear Medicine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Nuclear Medicine Market Size by Country (2019-2024)
9.3 Asia-Pacific Nuclear Medicine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Nuclear Medicine Market Size by Country (2019-2024)
10.3 Latin America Nuclear Medicine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Nuclear Medicine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Nuclear Medicine Market Size by Country (2019-2024)
11.3 Middle East & Africa Nuclear Medicine Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
LIST OF TABLES
Table 1. Global Nuclear Medicine Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global Nuclear Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global Nuclear Medicine Market Share by Region (2019-2024)
Table 4. Global Nuclear Medicine Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global Nuclear Medicine Market Share by Region (2025-2030)
Table 6. Global Nuclear Medicine Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Nuclear Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global Nuclear Medicine Market Size Share by Type (2019-2024)
Table 9. Global Nuclear Medicine Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global Nuclear Medicine Market Size Share Forecasted by Type (2025-2030)
Table 11. North America Nuclear Medicine Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America Nuclear Medicine Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe Nuclear Medicine Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe Nuclear Medicine Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific Nuclear Medicine Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific Nuclear Medicine Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America Nuclear Medicine Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America Nuclear Medicine Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa Nuclear Medicine Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa Nuclear Medicine Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global Nuclear Medicine Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global Nuclear Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Nuclear Medicine Market Size Share by Application (2019-2024)
Table 24. Global Nuclear Medicine Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global Nuclear Medicine Market Size Share Forecasted by Application (2025-2030)
Table 26. North America Nuclear Medicine Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America Nuclear Medicine Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe Nuclear Medicine Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe Nuclear Medicine Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific Nuclear Medicine Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific Nuclear Medicine Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America Nuclear Medicine Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America Nuclear Medicine Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa Nuclear Medicine Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa Nuclear Medicine Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. Nuclear Medicine Industry Trends
Table 37. Nuclear Medicine Industry Drivers
Table 38. Nuclear Medicine Industry Opportunities and Challenges
Table 39. Nuclear Medicine Industry Restraints
Table 40. Global Nuclear Medicine Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global Nuclear Medicine Revenue Market Share by Company (2019-2024)
Table 42. Global Nuclear Medicine Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global Nuclear Medicine Key Company Headquarters & Area Served
Table 44. Global Nuclear Medicine Company, Product Type & Application
Table 45. Global Nuclear Medicine Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Nuclear Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. GE Healthcare Business Overview
Table 49. GE Healthcare Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. GE Healthcare Nuclear Medicine Product Portfolio
Table 51. GE Healthcare Recent Development
Table 52. Bracco Imaging Company Information
Table 53. Bracco Imaging Business Overview
Table 54. Bracco Imaging Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Bracco Imaging Nuclear Medicine Product Portfolio
Table 56. Bracco Imaging Recent Development
Table 57. Mallinckrodt Company Information
Table 58. Mallinckrodt Business Overview
Table 59. Mallinckrodt Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. Mallinckrodt Nuclear Medicine Product Portfolio
Table 61. Mallinckrodt Recent Development
Table 62. Lantheus Medical Imaging Company Information
Table 63. Lantheus Medical Imaging Business Overview
Table 64. Lantheus Medical Imaging Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. Lantheus Medical Imaging Nuclear Medicine Product Portfolio
Table 66. Lantheus Medical Imaging Recent Development
Table 67. Bayer Company Information
Table 68. Bayer Business Overview
Table 69. Bayer Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. Bayer Nuclear Medicine Product Portfolio
Table 71. Bayer Recent Development
Table 72. Triad Isotopes Company Information
Table 73. Triad Isotopes Business Overview
Table 74. Triad Isotopes Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. Triad Isotopes Nuclear Medicine Product Portfolio
Table 76. Triad Isotopes Recent Development
Table 77. Nordion Company Information
Table 78. Nordion Business Overview
Table 79. Nordion Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Nordion Nuclear Medicine Product Portfolio
Table 81. Nordion Recent Development
Table 82. Jubilant Pharma Company Information
Table 83. Jubilant Pharma Business Overview
Table 84. Jubilant Pharma Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. Jubilant Pharma Nuclear Medicine Product Portfolio
Table 86. Jubilant Pharma Recent Development
Table 87. Eli Lilly Company Information
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. Eli Lilly Nuclear Medicine Product Portfolio
Table 91. Eli Lilly Recent Development
Table 92. SIEMENS Company Information
Table 93. SIEMENS Business Overview
Table 94. SIEMENS Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 95. SIEMENS Nuclear Medicine Product Portfolio
Table 96. SIEMENS Recent Development
Table 97. China Isotope & Radiation Company Information
Table 98. China Isotope & Radiation Business Overview
Table 99. China Isotope & Radiation Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 100. China Isotope & Radiation Nuclear Medicine Product Portfolio
Table 101. China Isotope & Radiation Recent Development
Table 102. Dongcheng Company Information
Table 103. Dongcheng Business Overview
Table 104. Dongcheng Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 105. Dongcheng Nuclear Medicine Product Portfolio
Table 106. Dongcheng Recent Development
Table 107. North America Nuclear Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 108. North America Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 109. North America Nuclear Medicine Market Share by Country (2019-2024)
Table 110. North America Nuclear Medicine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 111. North America Nuclear Medicine Market Share Forecast by Country (2025-2030)
Table 112. Europe Nuclear Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 113. Europe Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 114. Europe Nuclear Medicine Market Share by Country (2019-2024)
Table 115. Europe Nuclear Medicine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 116. Europe Nuclear Medicine Market Share Forecast by Country (2025-2030)
Table 117. Asia-Pacific Nuclear Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 118. Asia-Pacific Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 119. Asia-Pacific Nuclear Medicine Market Share by Country (2019-2024)
Table 120. Asia-Pacific Nuclear Medicine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 121. Asia-Pacific Nuclear Medicine Market Share Forecast by Country (2025-2030)
Table 122. Latin America Nuclear Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 123. Latin America Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 124. Latin America Nuclear Medicine Market Share by Country (2019-2024)
Table 125. Latin America Nuclear Medicine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 126. Latin America Nuclear Medicine Market Share Forecast by Country (2025-2030)
Table 127. Middle East & Africa Nuclear Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 128. Middle East & Africa Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 129. Middle East & Africa Nuclear Medicine Market Share by Country (2019-2024)
Table 130. Middle East & Africa Nuclear Medicine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 131. Middle East & Africa Nuclear Medicine Market Share Forecast by Country (2025-2030)
Table 132. Research Programs/Design for This Report
Table 133. Authors List of This Report
Table 134. Secondary Sources
Table 135. Primary Sources
Table 1. Global Nuclear Medicine Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global Nuclear Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global Nuclear Medicine Market Share by Region (2019-2024)
Table 4. Global Nuclear Medicine Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global Nuclear Medicine Market Share by Region (2025-2030)
Table 6. Global Nuclear Medicine Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Nuclear Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global Nuclear Medicine Market Size Share by Type (2019-2024)
Table 9. Global Nuclear Medicine Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global Nuclear Medicine Market Size Share Forecasted by Type (2025-2030)
Table 11. North America Nuclear Medicine Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America Nuclear Medicine Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe Nuclear Medicine Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe Nuclear Medicine Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific Nuclear Medicine Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific Nuclear Medicine Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America Nuclear Medicine Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America Nuclear Medicine Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa Nuclear Medicine Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa Nuclear Medicine Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global Nuclear Medicine Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global Nuclear Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Nuclear Medicine Market Size Share by Application (2019-2024)
Table 24. Global Nuclear Medicine Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global Nuclear Medicine Market Size Share Forecasted by Application (2025-2030)
Table 26. North America Nuclear Medicine Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America Nuclear Medicine Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe Nuclear Medicine Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe Nuclear Medicine Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific Nuclear Medicine Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific Nuclear Medicine Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America Nuclear Medicine Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America Nuclear Medicine Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa Nuclear Medicine Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa Nuclear Medicine Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. Nuclear Medicine Industry Trends
Table 37. Nuclear Medicine Industry Drivers
Table 38. Nuclear Medicine Industry Opportunities and Challenges
Table 39. Nuclear Medicine Industry Restraints
Table 40. Global Nuclear Medicine Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global Nuclear Medicine Revenue Market Share by Company (2019-2024)
Table 42. Global Nuclear Medicine Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global Nuclear Medicine Key Company Headquarters & Area Served
Table 44. Global Nuclear Medicine Company, Product Type & Application
Table 45. Global Nuclear Medicine Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Nuclear Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. GE Healthcare Business Overview
Table 49. GE Healthcare Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. GE Healthcare Nuclear Medicine Product Portfolio
Table 51. GE Healthcare Recent Development
Table 52. Bracco Imaging Company Information
Table 53. Bracco Imaging Business Overview
Table 54. Bracco Imaging Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Bracco Imaging Nuclear Medicine Product Portfolio
Table 56. Bracco Imaging Recent Development
Table 57. Mallinckrodt Company Information
Table 58. Mallinckrodt Business Overview
Table 59. Mallinckrodt Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. Mallinckrodt Nuclear Medicine Product Portfolio
Table 61. Mallinckrodt Recent Development
Table 62. Lantheus Medical Imaging Company Information
Table 63. Lantheus Medical Imaging Business Overview
Table 64. Lantheus Medical Imaging Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. Lantheus Medical Imaging Nuclear Medicine Product Portfolio
Table 66. Lantheus Medical Imaging Recent Development
Table 67. Bayer Company Information
Table 68. Bayer Business Overview
Table 69. Bayer Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. Bayer Nuclear Medicine Product Portfolio
Table 71. Bayer Recent Development
Table 72. Triad Isotopes Company Information
Table 73. Triad Isotopes Business Overview
Table 74. Triad Isotopes Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. Triad Isotopes Nuclear Medicine Product Portfolio
Table 76. Triad Isotopes Recent Development
Table 77. Nordion Company Information
Table 78. Nordion Business Overview
Table 79. Nordion Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Nordion Nuclear Medicine Product Portfolio
Table 81. Nordion Recent Development
Table 82. Jubilant Pharma Company Information
Table 83. Jubilant Pharma Business Overview
Table 84. Jubilant Pharma Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. Jubilant Pharma Nuclear Medicine Product Portfolio
Table 86. Jubilant Pharma Recent Development
Table 87. Eli Lilly Company Information
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. Eli Lilly Nuclear Medicine Product Portfolio
Table 91. Eli Lilly Recent Development
Table 92. SIEMENS Company Information
Table 93. SIEMENS Business Overview
Table 94. SIEMENS Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 95. SIEMENS Nuclear Medicine Product Portfolio
Table 96. SIEMENS Recent Development
Table 97. China Isotope & Radiation Company Information
Table 98. China Isotope & Radiation Business Overview
Table 99. China Isotope & Radiation Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 100. China Isotope & Radiation Nuclear Medicine Product Portfolio
Table 101. China Isotope & Radiation Recent Development
Table 102. Dongcheng Company Information
Table 103. Dongcheng Business Overview
Table 104. Dongcheng Nuclear Medicine Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 105. Dongcheng Nuclear Medicine Product Portfolio
Table 106. Dongcheng Recent Development
Table 107. North America Nuclear Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 108. North America Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 109. North America Nuclear Medicine Market Share by Country (2019-2024)
Table 110. North America Nuclear Medicine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 111. North America Nuclear Medicine Market Share Forecast by Country (2025-2030)
Table 112. Europe Nuclear Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 113. Europe Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 114. Europe Nuclear Medicine Market Share by Country (2019-2024)
Table 115. Europe Nuclear Medicine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 116. Europe Nuclear Medicine Market Share Forecast by Country (2025-2030)
Table 117. Asia-Pacific Nuclear Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 118. Asia-Pacific Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 119. Asia-Pacific Nuclear Medicine Market Share by Country (2019-2024)
Table 120. Asia-Pacific Nuclear Medicine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 121. Asia-Pacific Nuclear Medicine Market Share Forecast by Country (2025-2030)
Table 122. Latin America Nuclear Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 123. Latin America Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 124. Latin America Nuclear Medicine Market Share by Country (2019-2024)
Table 125. Latin America Nuclear Medicine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 126. Latin America Nuclear Medicine Market Share Forecast by Country (2025-2030)
Table 127. Middle East & Africa Nuclear Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 128. Middle East & Africa Nuclear Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 129. Middle East & Africa Nuclear Medicine Market Share by Country (2019-2024)
Table 130. Middle East & Africa Nuclear Medicine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 131. Middle East & Africa Nuclear Medicine Market Share Forecast by Country (2025-2030)
Table 132. Research Programs/Design for This Report
Table 133. Authors List of This Report
Table 134. Secondary Sources
Table 135. Primary Sources
LIST OF FIGURES
Figure 1. Nuclear Medicine Product Picture
Figure 2. Global Nuclear Medicine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Nuclear Medicine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Nuclear Medicine Market Share by Region: 2023 VS 2030
Figure 5. Global Nuclear Medicine Market Share by Region (2019-2030)
Figure 6. North America Nuclear Medicine Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe Nuclear Medicine Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific Nuclear Medicine Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America Nuclear Medicine Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa Nuclear Medicine Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Tc-99
Figure 12. Global Tc-99 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of I-123/131
Figure 14. Global I-123/131 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Product Picture of In-111
Figure 16. Global In-111 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. Product Picture of Xe-133
Figure 18. Global Xe-133 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Product Picture of Th-201
Figure 20. Global Th-201 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Product Picture of Ga-67
Figure 22. Global Ga-67 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Product Picture of Others
Figure 24. Global Others Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Global Nuclear Medicine Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 26. Global Nuclear Medicine Market Share by Type 2023 VS 2030
Figure 27. North America Nuclear Medicine Market Size Share by Type (2019-2030)
Figure 28. Europe Nuclear Medicine Market Size Share by Type (2019-2030)
Figure 29. Asia-Pacific Nuclear Medicine Market Size Share by Type (2019-2030)
Figure 30. Latin America Nuclear Medicine Market Size Share by Type (2019-2030)
Figure 31. Middle East and Africa Nuclear Medicine Market Size Share by Type (2019-2030)
Figure 32. Product Picture of Diagnostic
Figure 33. Global Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Product Picture of Therapeutic
Figure 35. Global Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Global Nuclear Medicine Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 37. Global Nuclear Medicine Market Share by Application 2023 VS 2030
Figure 38. North America Nuclear Medicine Market Size Share by Application (2019-2030)
Figure 39. Europe Nuclear Medicine Market Size Share by Application (2019-2030)
Figure 40. Asia-Pacific Nuclear Medicine Market Size Share by Application (2019-2030)
Figure 41. Latin America Nuclear Medicine Market Size Share by Application (2019-2030)
Figure 42. Middle East and Africa Nuclear Medicine Market Size Share by Application (2019-2030)
Figure 43. Global Top 5 and 10 Nuclear Medicine Players Market Share by Revenue in 2023
Figure 44. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 45. North America Nuclear Medicine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 46. North America Nuclear Medicine Market Share by Country: 2019 VS 2023 VS 2030
Figure 47. North America Nuclear Medicine Market Share by Country (2019-2030)
Figure 48. Europe Nuclear Medicine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 49. Europe Nuclear Medicine Market Share by Country: 2019 VS 2023 VS 2030
Figure 50. Europe Nuclear Medicine Market Share by Country (2019-2030)
Figure 51. Asia-Pacific Nuclear Medicine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 52. Asia-Pacific Nuclear Medicine Market Share by Country: 2019 VS 2023 VS 2030
Figure 53. Asia-Pacific Nuclear Medicine Market Share by Country (2019-2030)
Figure 54. Latin America Nuclear Medicine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 55. Latin America Nuclear Medicine Market Share by Country: 2019 VS 2023 VS 2030
Figure 56. Latin America Nuclear Medicine Market Share by Country (2019-2030)
Figure 57. Middle East & Africa Nuclear Medicine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 58. Middle East & Africa Nuclear Medicine Market Share by Country: 2019 VS 2023 VS 2030
Figure 59. Middle East & Africa Nuclear Medicine Market Share by Country (2019-2030)
Figure 60. Years Considered
Figure 61. Research Process
Figure 62. Key Executives Interviewed
Figure 1. Nuclear Medicine Product Picture
Figure 2. Global Nuclear Medicine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Nuclear Medicine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Nuclear Medicine Market Share by Region: 2023 VS 2030
Figure 5. Global Nuclear Medicine Market Share by Region (2019-2030)
Figure 6. North America Nuclear Medicine Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe Nuclear Medicine Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific Nuclear Medicine Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America Nuclear Medicine Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa Nuclear Medicine Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Tc-99
Figure 12. Global Tc-99 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of I-123/131
Figure 14. Global I-123/131 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Product Picture of In-111
Figure 16. Global In-111 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. Product Picture of Xe-133
Figure 18. Global Xe-133 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Product Picture of Th-201
Figure 20. Global Th-201 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Product Picture of Ga-67
Figure 22. Global Ga-67 Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Product Picture of Others
Figure 24. Global Others Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Global Nuclear Medicine Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 26. Global Nuclear Medicine Market Share by Type 2023 VS 2030
Figure 27. North America Nuclear Medicine Market Size Share by Type (2019-2030)
Figure 28. Europe Nuclear Medicine Market Size Share by Type (2019-2030)
Figure 29. Asia-Pacific Nuclear Medicine Market Size Share by Type (2019-2030)
Figure 30. Latin America Nuclear Medicine Market Size Share by Type (2019-2030)
Figure 31. Middle East and Africa Nuclear Medicine Market Size Share by Type (2019-2030)
Figure 32. Product Picture of Diagnostic
Figure 33. Global Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Product Picture of Therapeutic
Figure 35. Global Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Global Nuclear Medicine Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 37. Global Nuclear Medicine Market Share by Application 2023 VS 2030
Figure 38. North America Nuclear Medicine Market Size Share by Application (2019-2030)
Figure 39. Europe Nuclear Medicine Market Size Share by Application (2019-2030)
Figure 40. Asia-Pacific Nuclear Medicine Market Size Share by Application (2019-2030)
Figure 41. Latin America Nuclear Medicine Market Size Share by Application (2019-2030)
Figure 42. Middle East and Africa Nuclear Medicine Market Size Share by Application (2019-2030)
Figure 43. Global Top 5 and 10 Nuclear Medicine Players Market Share by Revenue in 2023
Figure 44. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 45. North America Nuclear Medicine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 46. North America Nuclear Medicine Market Share by Country: 2019 VS 2023 VS 2030
Figure 47. North America Nuclear Medicine Market Share by Country (2019-2030)
Figure 48. Europe Nuclear Medicine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 49. Europe Nuclear Medicine Market Share by Country: 2019 VS 2023 VS 2030
Figure 50. Europe Nuclear Medicine Market Share by Country (2019-2030)
Figure 51. Asia-Pacific Nuclear Medicine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 52. Asia-Pacific Nuclear Medicine Market Share by Country: 2019 VS 2023 VS 2030
Figure 53. Asia-Pacific Nuclear Medicine Market Share by Country (2019-2030)
Figure 54. Latin America Nuclear Medicine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 55. Latin America Nuclear Medicine Market Share by Country: 2019 VS 2023 VS 2030
Figure 56. Latin America Nuclear Medicine Market Share by Country (2019-2030)
Figure 57. Middle East & Africa Nuclear Medicine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 58. Middle East & Africa Nuclear Medicine Market Share by Country: 2019 VS 2023 VS 2030
Figure 59. Middle East & Africa Nuclear Medicine Market Share by Country (2019-2030)
Figure 60. Years Considered
Figure 61. Research Process
Figure 62. Key Executives Interviewed
